nodes	percent_of_prediction	percent_of_DWPC	metapath
Olanzapine—CYP1A2—Dacarbazine—muscle cancer	0.118	0.191	CbGbCtD
Olanzapine—ABCB1—Dactinomycin—muscle cancer	0.0894	0.145	CbGbCtD
Olanzapine—ALB—Methotrexate—muscle cancer	0.0637	0.103	CbGbCtD
Olanzapine—CYP1A2—Etoposide—muscle cancer	0.0577	0.0933	CbGbCtD
Olanzapine—ABCB1—Vincristine—muscle cancer	0.055	0.0891	CbGbCtD
Olanzapine—ABCB1—Etoposide—muscle cancer	0.0504	0.0816	CbGbCtD
Olanzapine—ABCB1—Doxorubicin—muscle cancer	0.0344	0.0557	CbGbCtD
Olanzapine—ABCB1—Methotrexate—muscle cancer	0.0333	0.0539	CbGbCtD
Olanzapine—CYP3A4—Vincristine—muscle cancer	0.033	0.0534	CbGbCtD
Olanzapine—CYP2D6—Doxorubicin—muscle cancer	0.0324	0.0525	CbGbCtD
Olanzapine—CYP3A4—Etoposide—muscle cancer	0.0302	0.0489	CbGbCtD
Olanzapine—CHRM3—muscle of abdomen—muscle cancer	0.0293	0.0933	CbGeAlD
Olanzapine—CYP3A4—Doxorubicin—muscle cancer	0.0206	0.0334	CbGbCtD
Olanzapine—HTR5A—head—muscle cancer	0.0133	0.0422	CbGeAlD
Olanzapine—HRH4—bone marrow—muscle cancer	0.0109	0.0347	CbGeAlD
Olanzapine—HTR2A—hindlimb—muscle cancer	0.00892	0.0284	CbGeAlD
Olanzapine—HTR2A—appendage—muscle cancer	0.00765	0.0243	CbGeAlD
Olanzapine—H1F0—embryo—muscle cancer	0.0066	0.021	CbGeAlD
Olanzapine—DRD4—testis—muscle cancer	0.00634	0.0202	CbGeAlD
Olanzapine—HTR1E—head—muscle cancer	0.00566	0.018	CbGeAlD
Olanzapine—HRH2—cardiac atrium—muscle cancer	0.00543	0.0173	CbGeAlD
Olanzapine—ADRA1B—renal system—muscle cancer	0.00529	0.0168	CbGeAlD
Olanzapine—H1F0—smooth muscle tissue—muscle cancer	0.00519	0.0165	CbGeAlD
Olanzapine—H1F0—renal system—muscle cancer	0.005	0.0159	CbGeAlD
Olanzapine—CHRM4—head—muscle cancer	0.00496	0.0158	CbGeAlD
Olanzapine—FMO3—vagina—muscle cancer	0.00494	0.0157	CbGeAlD
Olanzapine—CHRM4—testis—muscle cancer	0.00479	0.0152	CbGeAlD
Olanzapine—DRD3—head—muscle cancer	0.00461	0.0147	CbGeAlD
Olanzapine—FMO3—head—muscle cancer	0.00456	0.0145	CbGeAlD
Olanzapine—H1F0—cardiac atrium—muscle cancer	0.00448	0.0142	CbGeAlD
Olanzapine—HTR6—head—muscle cancer	0.00444	0.0141	CbGeAlD
Olanzapine—FMO3—testis—muscle cancer	0.0044	0.014	CbGeAlD
Olanzapine—DRD5—head—muscle cancer	0.00432	0.0137	CbGeAlD
Olanzapine—HRH2—head—muscle cancer	0.00406	0.0129	CbGeAlD
Olanzapine—H1F0—tendon—muscle cancer	0.0039	0.0124	CbGeAlD
Olanzapine—CHRM5—head—muscle cancer	0.00388	0.0123	CbGeAlD
Olanzapine—H1F0—bone marrow—muscle cancer	0.00378	0.012	CbGeAlD
Olanzapine—HTR2B—smooth muscle tissue—muscle cancer	0.00374	0.0119	CbGeAlD
Olanzapine—H1F0—vagina—muscle cancer	0.00362	0.0115	CbGeAlD
Olanzapine—ADRA1B—head—muscle cancer	0.00354	0.0113	CbGeAlD
Olanzapine—CHRM3—smooth muscle tissue—muscle cancer	0.00337	0.0107	CbGeAlD
Olanzapine—H1F0—head—muscle cancer	0.00334	0.0106	CbGeAlD
Olanzapine—DRD1—head—muscle cancer	0.0033	0.0105	CbGeAlD
Olanzapine—CHRM3—renal system—muscle cancer	0.00324	0.0103	CbGeAlD
Olanzapine—H1F0—testis—muscle cancer	0.00323	0.0103	CbGeAlD
Olanzapine—HTR1A—renal system—muscle cancer	0.00323	0.0103	CbGeAlD
Olanzapine—ORM1—bone marrow—muscle cancer	0.00322	0.0103	CbGeAlD
Olanzapine—HTR7—smooth muscle tissue—muscle cancer	0.0032	0.0102	CbGeAlD
Olanzapine—HTR3A—head—muscle cancer	0.00319	0.0101	CbGeAlD
Olanzapine—HTR7—renal system—muscle cancer	0.00308	0.00981	CbGeAlD
Olanzapine—ADRA1A—renal system—muscle cancer	0.00297	0.00946	CbGeAlD
Olanzapine—ADRA2C—renal system—muscle cancer	0.00283	0.00902	CbGeAlD
Olanzapine—HTR2B—tendon—muscle cancer	0.00281	0.00894	CbGeAlD
Olanzapine—HTR1B—head—muscle cancer	0.00268	0.00851	CbGeAlD
Olanzapine—CHRM2—head—muscle cancer	0.00266	0.00846	CbGeAlD
Olanzapine—HTR2B—vagina—muscle cancer	0.00261	0.0083	CbGeAlD
Olanzapine—HTR1D—head—muscle cancer	0.00259	0.00824	CbGeAlD
Olanzapine—HTR2C—head—muscle cancer	0.00256	0.00816	CbGeAlD
Olanzapine—HTR2A—embryo—muscle cancer	0.00254	0.00808	CbGeAlD
Olanzapine—ADRA2C—cardiac atrium—muscle cancer	0.00254	0.00807	CbGeAlD
Olanzapine—CYP1A2—renal system—muscle cancer	0.00246	0.00782	CbGeAlD
Olanzapine—CHRM1—head—muscle cancer	0.00242	0.00771	CbGeAlD
Olanzapine—ALB—testis—muscle cancer	0.00242	0.00769	CbGeAlD
Olanzapine—HTR2B—head—muscle cancer	0.00241	0.00766	CbGeAlD
Olanzapine—HTR7—tendon—muscle cancer	0.00241	0.00766	CbGeAlD
Olanzapine—HRH1—smooth muscle tissue—muscle cancer	0.00239	0.00761	CbGeAlD
Olanzapine—ADRA2C—tendon—muscle cancer	0.00221	0.00704	CbGeAlD
Olanzapine—CYP2C19—vagina—muscle cancer	0.00218	0.00694	CbGeAlD
Olanzapine—CHRM3—head—muscle cancer	0.00217	0.0069	CbGeAlD
Olanzapine—HTR1A—head—muscle cancer	0.00216	0.00687	CbGeAlD
Olanzapine—CHRM3—testis—muscle cancer	0.00209	0.00666	CbGeAlD
Olanzapine—HTR7—head—muscle cancer	0.00206	0.00656	CbGeAlD
Olanzapine—ADRA2C—vagina—muscle cancer	0.00205	0.00653	CbGeAlD
Olanzapine—ADRA2A—cardiac atrium—muscle cancer	0.00203	0.00644	CbGeAlD
Olanzapine—HTR2A—smooth muscle tissue—muscle cancer	0.002	0.00635	CbGeAlD
Olanzapine—HTR7—testis—muscle cancer	0.00199	0.00634	CbGeAlD
Olanzapine—ADRA1A—head—muscle cancer	0.00199	0.00633	CbGeAlD
Olanzapine—DRD2—head—muscle cancer	0.00195	0.00621	CbGeAlD
Olanzapine—HTR2A—renal system—muscle cancer	0.00192	0.00612	CbGeAlD
Olanzapine—ADRA2C—head—muscle cancer	0.0019	0.00603	CbGeAlD
Olanzapine—DRD2—testis—muscle cancer	0.00188	0.00599	CbGeAlD
Olanzapine—ADRA2C—testis—muscle cancer	0.00183	0.00583	CbGeAlD
Olanzapine—HRH1—tendon—muscle cancer	0.0018	0.00572	CbGeAlD
Olanzapine—CYP3A4—renal system—muscle cancer	0.00178	0.00566	CbGeAlD
Olanzapine—ADRA2A—tendon—muscle cancer	0.00177	0.00562	CbGeAlD
Olanzapine—CYP2D6—renal system—muscle cancer	0.00175	0.00557	CbGeAlD
Olanzapine—HRH1—vagina—muscle cancer	0.00167	0.00531	CbGeAlD
Olanzapine—ABCB1—embryo—muscle cancer	0.00166	0.0053	CbGeAlD
Olanzapine—ADRA2A—vagina—muscle cancer	0.00164	0.00521	CbGeAlD
Olanzapine—HRH1—head—muscle cancer	0.00154	0.0049	CbGeAlD
Olanzapine—ADRA2A—head—muscle cancer	0.00151	0.00481	CbGeAlD
Olanzapine—HTR2A—tendon—muscle cancer	0.0015	0.00477	CbGeAlD
Olanzapine—HRH1—testis—muscle cancer	0.00149	0.00473	CbGeAlD
Olanzapine—ADRA2A—testis—muscle cancer	0.00146	0.00465	CbGeAlD
Olanzapine—HTR2A—vagina—muscle cancer	0.00139	0.00443	CbGeAlD
Olanzapine—HTR2A—head—muscle cancer	0.00129	0.00409	CbGeAlD
Olanzapine—ABCB1—renal system—muscle cancer	0.00126	0.00401	CbGeAlD
Olanzapine—HTR2A—testis—muscle cancer	0.00124	0.00395	CbGeAlD
Olanzapine—CYP2D6—head—muscle cancer	0.00117	0.00373	CbGeAlD
Olanzapine—CYP2D6—testis—muscle cancer	0.00113	0.0036	CbGeAlD
Olanzapine—ABCB1—bone marrow—muscle cancer	0.000953	0.00303	CbGeAlD
Olanzapine—ABCB1—vagina—muscle cancer	0.000913	0.0029	CbGeAlD
Olanzapine—ABCB1—head—muscle cancer	0.000843	0.00268	CbGeAlD
Olanzapine—ABCB1—testis—muscle cancer	0.000815	0.00259	CbGeAlD
Olanzapine—CHRM4—Signaling Pathways—FOXO4—muscle cancer	4.23e-05	0.000624	CbGpPWpGaD
Olanzapine—DRD4—Signaling Pathways—CNR1—muscle cancer	4.2e-05	0.000621	CbGpPWpGaD
Olanzapine—ADRA2A—Metabolism—MED12—muscle cancer	4.19e-05	0.000619	CbGpPWpGaD
Olanzapine—FMO3—Metabolism—PTGS2—muscle cancer	4.17e-05	0.000616	CbGpPWpGaD
Olanzapine—CHRM3—Metabolism—ENO2—muscle cancer	4.17e-05	0.000615	CbGpPWpGaD
Olanzapine—CHRM4—Signaling Pathways—CNR1—muscle cancer	4.15e-05	0.000613	CbGpPWpGaD
Olanzapine—CYP1A2—Metabolism—FH—muscle cancer	4.1e-05	0.000605	CbGpPWpGaD
Olanzapine—HTR2B—Signaling Pathways—FOXO4—muscle cancer	4.09e-05	0.000604	CbGpPWpGaD
Olanzapine—HTR5A—Signaling Pathways—VEGFA—muscle cancer	4.09e-05	0.000604	CbGpPWpGaD
Olanzapine—CHRM5—Signaling Pathways—FOXO4—muscle cancer	4.05e-05	0.000598	CbGpPWpGaD
Olanzapine—HTR2B—Signaling Pathways—CNR1—muscle cancer	4.01e-05	0.000593	CbGpPWpGaD
Olanzapine—ADRA2B—Signaling Pathways—PTCH1—muscle cancer	4e-05	0.00059	CbGpPWpGaD
Olanzapine—CHRM5—Signaling Pathways—CNR1—muscle cancer	3.97e-05	0.000587	CbGpPWpGaD
Olanzapine—ALB—Platelet activation, signaling and aggregation—VEGFA—muscle cancer	3.96e-05	0.000585	CbGpPWpGaD
Olanzapine—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—muscle cancer	3.9e-05	0.000576	CbGpPWpGaD
Olanzapine—DRD1—Signaling Pathways—FOXO4—muscle cancer	3.86e-05	0.00057	CbGpPWpGaD
Olanzapine—HTR1A—Signaling Pathways—PTCH1—muscle cancer	3.86e-05	0.00057	CbGpPWpGaD
Olanzapine—HTR2C—Signaling Pathways—PTCH1—muscle cancer	3.84e-05	0.000567	CbGpPWpGaD
Olanzapine—ADRA2A—Metabolism—ENO2—muscle cancer	3.82e-05	0.000565	CbGpPWpGaD
Olanzapine—DRD3—Signaling Pathways—FOXO4—muscle cancer	3.81e-05	0.000562	CbGpPWpGaD
Olanzapine—DRD1—Signaling Pathways—CNR1—muscle cancer	3.79e-05	0.000559	CbGpPWpGaD
Olanzapine—DRD3—Signaling Pathways—CNR1—muscle cancer	3.74e-05	0.000552	CbGpPWpGaD
Olanzapine—ADRA2C—Signaling Pathways—PTCH1—muscle cancer	3.73e-05	0.000551	CbGpPWpGaD
Olanzapine—HTR1E—Signaling Pathways—KIT—muscle cancer	3.69e-05	0.000545	CbGpPWpGaD
Olanzapine—ADRA1B—Signaling Pathways—PTCH1—muscle cancer	3.67e-05	0.000542	CbGpPWpGaD
Olanzapine—HTR6—Signaling Pathways—IGF2—muscle cancer	3.6e-05	0.000531	CbGpPWpGaD
Olanzapine—HTR7—Signaling Pathways—IGF2—muscle cancer	3.59e-05	0.00053	CbGpPWpGaD
Olanzapine—HTR1D—Signaling Pathways—IGF2—muscle cancer	3.57e-05	0.000527	CbGpPWpGaD
Olanzapine—HTR1B—Signaling Pathways—IGF2—muscle cancer	3.49e-05	0.000516	CbGpPWpGaD
Olanzapine—DRD4—Signaling Pathways—IGF2—muscle cancer	3.44e-05	0.000508	CbGpPWpGaD
Olanzapine—ADRA2B—Signaling Pathways—FOXO4—muscle cancer	3.44e-05	0.000507	CbGpPWpGaD
Olanzapine—ADRA2B—Hemostasis—VEGFA—muscle cancer	3.41e-05	0.000504	CbGpPWpGaD
Olanzapine—CHRM4—Signaling Pathways—IGF2—muscle cancer	3.39e-05	0.000501	CbGpPWpGaD
Olanzapine—DRD2—Signaling Pathways—PTCH1—muscle cancer	3.39e-05	0.0005	CbGpPWpGaD
Olanzapine—ADRA2B—Signaling Pathways—CNR1—muscle cancer	3.37e-05	0.000498	CbGpPWpGaD
Olanzapine—HRH4—Signaling Pathways—MDM2—muscle cancer	3.34e-05	0.000493	CbGpPWpGaD
Olanzapine—HTR2A—Signaling Pathways—PTCH1—muscle cancer	3.33e-05	0.000492	CbGpPWpGaD
Olanzapine—HRH1—Signaling Pathways—PTCH1—muscle cancer	3.32e-05	0.000491	CbGpPWpGaD
Olanzapine—HTR1A—Signaling Pathways—FOXO4—muscle cancer	3.32e-05	0.00049	CbGpPWpGaD
Olanzapine—CHRM1—Signaling Pathways—PTCH1—muscle cancer	3.31e-05	0.000489	CbGpPWpGaD
Olanzapine—ALB—Metabolism—MED12—muscle cancer	3.31e-05	0.000489	CbGpPWpGaD
Olanzapine—HTR6—Signaling Pathways—FOXO1—muscle cancer	3.31e-05	0.000489	CbGpPWpGaD
Olanzapine—HTR7—Signaling Pathways—FOXO1—muscle cancer	3.31e-05	0.000488	CbGpPWpGaD
Olanzapine—CHRM3—Signaling Pathways—PTCH1—muscle cancer	3.3e-05	0.000488	CbGpPWpGaD
Olanzapine—HTR2C—Signaling Pathways—FOXO4—muscle cancer	3.3e-05	0.000487	CbGpPWpGaD
Olanzapine—HRH2—Signaling Pathways—KIT—muscle cancer	3.29e-05	0.000485	CbGpPWpGaD
Olanzapine—HTR1D—Signaling Pathways—FOXO1—muscle cancer	3.28e-05	0.000485	CbGpPWpGaD
Olanzapine—HTR2B—Signaling Pathways—IGF2—muscle cancer	3.28e-05	0.000485	CbGpPWpGaD
Olanzapine—CHRM2—Signaling Pathways—PTCH1—muscle cancer	3.27e-05	0.000483	CbGpPWpGaD
Olanzapine—DRD5—Signaling Pathways—KIT—muscle cancer	3.27e-05	0.000482	CbGpPWpGaD
Olanzapine—ADRA1A—Signaling Pathways—PTCH1—muscle cancer	3.26e-05	0.000482	CbGpPWpGaD
Olanzapine—HTR1A—Signaling Pathways—CNR1—muscle cancer	3.26e-05	0.000481	CbGpPWpGaD
Olanzapine—CHRM5—Signaling Pathways—IGF2—muscle cancer	3.25e-05	0.00048	CbGpPWpGaD
Olanzapine—HTR2C—Signaling Pathways—CNR1—muscle cancer	3.24e-05	0.000478	CbGpPWpGaD
Olanzapine—HTR1B—Signaling Pathways—FOXO1—muscle cancer	3.22e-05	0.000475	CbGpPWpGaD
Olanzapine—ADRA2C—Signaling Pathways—FOXO4—muscle cancer	3.21e-05	0.000474	CbGpPWpGaD
Olanzapine—ADRA2C—Hemostasis—VEGFA—muscle cancer	3.19e-05	0.00047	CbGpPWpGaD
Olanzapine—DRD4—Signaling Pathways—FOXO1—muscle cancer	3.16e-05	0.000467	CbGpPWpGaD
Olanzapine—CYP3A4—Metabolism—FH—muscle cancer	3.16e-05	0.000467	CbGpPWpGaD
Olanzapine—ADRA1B—Signaling Pathways—FOXO4—muscle cancer	3.16e-05	0.000466	CbGpPWpGaD
Olanzapine—ADRA2C—Signaling Pathways—CNR1—muscle cancer	3.15e-05	0.000465	CbGpPWpGaD
Olanzapine—CHRM4—Signaling Pathways—FOXO1—muscle cancer	3.12e-05	0.000461	CbGpPWpGaD
Olanzapine—ADRA1B—Signaling Pathways—CNR1—muscle cancer	3.1e-05	0.000458	CbGpPWpGaD
Olanzapine—DRD1—Signaling Pathways—IGF2—muscle cancer	3.09e-05	0.000457	CbGpPWpGaD
Olanzapine—HTR5A—Signaling Pathways—TP53—muscle cancer	3.09e-05	0.000456	CbGpPWpGaD
Olanzapine—DRD3—Signaling Pathways—IGF2—muscle cancer	3.05e-05	0.000451	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling Pathways—PTCH1—muscle cancer	3.03e-05	0.000448	CbGpPWpGaD
Olanzapine—HTR2B—Signaling Pathways—FOXO1—muscle cancer	3.02e-05	0.000446	CbGpPWpGaD
Olanzapine—ALB—Metabolism—ENO2—muscle cancer	3.02e-05	0.000446	CbGpPWpGaD
Olanzapine—CHRM5—Signaling Pathways—FOXO1—muscle cancer	2.99e-05	0.000441	CbGpPWpGaD
Olanzapine—CYP2C19—Metabolism—MED12—muscle cancer	2.97e-05	0.000439	CbGpPWpGaD
Olanzapine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—muscle cancer	2.95e-05	0.000435	CbGpPWpGaD
Olanzapine—DRD2—Signaling Pathways—FOXO4—muscle cancer	2.91e-05	0.00043	CbGpPWpGaD
Olanzapine—HTR1E—Signaling Pathways—MDM2—muscle cancer	2.91e-05	0.000429	CbGpPWpGaD
Olanzapine—ABCB1—Metabolism—MED12—muscle cancer	2.9e-05	0.000428	CbGpPWpGaD
Olanzapine—HTR2A—Signaling Pathways—FOXO4—muscle cancer	2.87e-05	0.000423	CbGpPWpGaD
Olanzapine—HRH1—Signaling Pathways—FOXO4—muscle cancer	2.86e-05	0.000422	CbGpPWpGaD
Olanzapine—DRD2—Signaling Pathways—CNR1—muscle cancer	2.86e-05	0.000422	CbGpPWpGaD
Olanzapine—CHRM1—Signaling Pathways—FOXO4—muscle cancer	2.85e-05	0.000421	CbGpPWpGaD
Olanzapine—DRD1—Signaling Pathways—FOXO1—muscle cancer	2.85e-05	0.000421	CbGpPWpGaD
Olanzapine—CHRM3—Signaling Pathways—FOXO4—muscle cancer	2.84e-05	0.000419	CbGpPWpGaD
Olanzapine—CHRM2—Signaling Pathways—FOXO4—muscle cancer	2.81e-05	0.000415	CbGpPWpGaD
Olanzapine—HTR2A—Signaling Pathways—CNR1—muscle cancer	2.81e-05	0.000415	CbGpPWpGaD
Olanzapine—DRD3—Signaling Pathways—FOXO1—muscle cancer	2.81e-05	0.000415	CbGpPWpGaD
Olanzapine—HRH1—Signaling Pathways—CNR1—muscle cancer	2.81e-05	0.000414	CbGpPWpGaD
Olanzapine—ADRA1A—Signaling Pathways—FOXO4—muscle cancer	2.81e-05	0.000414	CbGpPWpGaD
Olanzapine—CHRM1—Signaling Pathways—CNR1—muscle cancer	2.8e-05	0.000413	CbGpPWpGaD
Olanzapine—CHRM3—Signaling Pathways—CNR1—muscle cancer	2.79e-05	0.000412	CbGpPWpGaD
Olanzapine—CHRM2—Signaling Pathways—CNR1—muscle cancer	2.76e-05	0.000408	CbGpPWpGaD
Olanzapine—ADRA2B—Signaling Pathways—IGF2—muscle cancer	2.76e-05	0.000407	CbGpPWpGaD
Olanzapine—ADRA1A—Signaling Pathways—CNR1—muscle cancer	2.75e-05	0.000407	CbGpPWpGaD
Olanzapine—CYP2D6—Metabolism—MED12—muscle cancer	2.73e-05	0.000404	CbGpPWpGaD
Olanzapine—CYP2C9—Metabolism—MED12—muscle cancer	2.71e-05	0.0004	CbGpPWpGaD
Olanzapine—CYP2C19—Metabolism—ENO2—muscle cancer	2.71e-05	0.0004	CbGpPWpGaD
Olanzapine—HTR1A—Signaling Pathways—IGF2—muscle cancer	2.66e-05	0.000393	CbGpPWpGaD
Olanzapine—HTR2C—Signaling Pathways—IGF2—muscle cancer	2.65e-05	0.000391	CbGpPWpGaD
Olanzapine—ABCB1—Metabolism—ENO2—muscle cancer	2.64e-05	0.00039	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling Pathways—FOXO4—muscle cancer	2.61e-05	0.000385	CbGpPWpGaD
Olanzapine—HRH2—Signaling Pathways—MDM2—muscle cancer	2.59e-05	0.000382	CbGpPWpGaD
Olanzapine—ADRA2A—Hemostasis—VEGFA—muscle cancer	2.59e-05	0.000382	CbGpPWpGaD
Olanzapine—ADRA2B—Hemostasis—TP53—muscle cancer	2.58e-05	0.000381	CbGpPWpGaD
Olanzapine—ADRA2C—Signaling Pathways—IGF2—muscle cancer	2.58e-05	0.00038	CbGpPWpGaD
Olanzapine—DRD5—Signaling Pathways—MDM2—muscle cancer	2.57e-05	0.00038	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling Pathways—CNR1—muscle cancer	2.56e-05	0.000378	CbGpPWpGaD
Olanzapine—ADRA2B—Signaling Pathways—FOXO1—muscle cancer	2.54e-05	0.000375	CbGpPWpGaD
Olanzapine—HRH4—Signaling Pathways—VEGFA—muscle cancer	2.54e-05	0.000374	CbGpPWpGaD
Olanzapine—ADRA1B—Signaling Pathways—IGF2—muscle cancer	2.53e-05	0.000374	CbGpPWpGaD
Olanzapine—HTR6—Signaling Pathways—KIT—muscle cancer	2.52e-05	0.000372	CbGpPWpGaD
Olanzapine—HTR7—Signaling Pathways—KIT—muscle cancer	2.52e-05	0.000372	CbGpPWpGaD
Olanzapine—HTR1D—Signaling Pathways—KIT—muscle cancer	2.5e-05	0.000369	CbGpPWpGaD
Olanzapine—CYP2D6—Metabolism—ENO2—muscle cancer	2.49e-05	0.000368	CbGpPWpGaD
Olanzapine—CYP2C9—Metabolism—ENO2—muscle cancer	2.47e-05	0.000365	CbGpPWpGaD
Olanzapine—HTR1B—Signaling Pathways—KIT—muscle cancer	2.45e-05	0.000362	CbGpPWpGaD
Olanzapine—HTR1A—Signaling Pathways—FOXO1—muscle cancer	2.45e-05	0.000362	CbGpPWpGaD
Olanzapine—HTR2C—Signaling Pathways—FOXO1—muscle cancer	2.44e-05	0.00036	CbGpPWpGaD
Olanzapine—DRD4—Signaling Pathways—KIT—muscle cancer	2.41e-05	0.000356	CbGpPWpGaD
Olanzapine—ADRA2C—Hemostasis—TP53—muscle cancer	2.41e-05	0.000355	CbGpPWpGaD
Olanzapine—CHRM4—Signaling Pathways—KIT—muscle cancer	2.38e-05	0.000351	CbGpPWpGaD
Olanzapine—ADRA2C—Signaling Pathways—FOXO1—muscle cancer	2.37e-05	0.00035	CbGpPWpGaD
Olanzapine—ALB—Metabolism of lipids and lipoproteins—PTGS2—muscle cancer	2.36e-05	0.000349	CbGpPWpGaD
Olanzapine—DRD2—Signaling Pathways—IGF2—muscle cancer	2.34e-05	0.000345	CbGpPWpGaD
Olanzapine—ADRA1B—Signaling Pathways—FOXO1—muscle cancer	2.33e-05	0.000344	CbGpPWpGaD
Olanzapine—CYP1A2—Metabolism—MED12—muscle cancer	2.32e-05	0.000342	CbGpPWpGaD
Olanzapine—HTR2B—Signaling Pathways—KIT—muscle cancer	2.3e-05	0.00034	CbGpPWpGaD
Olanzapine—HTR2A—Signaling Pathways—IGF2—muscle cancer	2.3e-05	0.00034	CbGpPWpGaD
Olanzapine—HRH1—Signaling Pathways—IGF2—muscle cancer	2.29e-05	0.000339	CbGpPWpGaD
Olanzapine—CHRM1—Signaling Pathways—IGF2—muscle cancer	2.29e-05	0.000338	CbGpPWpGaD
Olanzapine—CHRM3—Signaling Pathways—IGF2—muscle cancer	2.28e-05	0.000337	CbGpPWpGaD
Olanzapine—CHRM5—Signaling Pathways—KIT—muscle cancer	2.28e-05	0.000336	CbGpPWpGaD
Olanzapine—CHRM2—Signaling Pathways—IGF2—muscle cancer	2.26e-05	0.000333	CbGpPWpGaD
Olanzapine—ADRA1A—Signaling Pathways—IGF2—muscle cancer	2.25e-05	0.000332	CbGpPWpGaD
Olanzapine—HTR1E—Signaling Pathways—VEGFA—muscle cancer	2.21e-05	0.000326	CbGpPWpGaD
Olanzapine—DRD1—Signaling Pathways—KIT—muscle cancer	2.17e-05	0.00032	CbGpPWpGaD
Olanzapine—DRD2—Signaling Pathways—FOXO1—muscle cancer	2.15e-05	0.000318	CbGpPWpGaD
Olanzapine—DRD3—Signaling Pathways—KIT—muscle cancer	2.14e-05	0.000316	CbGpPWpGaD
Olanzapine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—muscle cancer	2.12e-05	0.000313	CbGpPWpGaD
Olanzapine—HTR2A—Signaling Pathways—FOXO1—muscle cancer	2.12e-05	0.000312	CbGpPWpGaD
Olanzapine—HRH1—Signaling Pathways—FOXO1—muscle cancer	2.11e-05	0.000312	CbGpPWpGaD
Olanzapine—CYP1A2—Metabolism—ENO2—muscle cancer	2.11e-05	0.000312	CbGpPWpGaD
Olanzapine—CHRM1—Signaling Pathways—FOXO1—muscle cancer	2.1e-05	0.000311	CbGpPWpGaD
Olanzapine—CHRM3—Signaling Pathways—FOXO1—muscle cancer	2.1e-05	0.00031	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling Pathways—IGF2—muscle cancer	2.09e-05	0.000309	CbGpPWpGaD
Olanzapine—CHRM2—Signaling Pathways—FOXO1—muscle cancer	2.08e-05	0.000307	CbGpPWpGaD
Olanzapine—ADRA1A—Signaling Pathways—FOXO1—muscle cancer	2.07e-05	0.000306	CbGpPWpGaD
Olanzapine—ALB—Hemostasis—VEGFA—muscle cancer	2.04e-05	0.000302	CbGpPWpGaD
Olanzapine—HTR6—Signaling Pathways—MDM2—muscle cancer	1.99e-05	0.000293	CbGpPWpGaD
Olanzapine—HTR7—Signaling Pathways—MDM2—muscle cancer	1.98e-05	0.000293	CbGpPWpGaD
Olanzapine—HTR1D—Signaling Pathways—MDM2—muscle cancer	1.97e-05	0.000291	CbGpPWpGaD
Olanzapine—HRH2—Signaling Pathways—VEGFA—muscle cancer	1.97e-05	0.00029	CbGpPWpGaD
Olanzapine—ADRA2A—Hemostasis—TP53—muscle cancer	1.96e-05	0.000289	CbGpPWpGaD
Olanzapine—DRD5—Signaling Pathways—VEGFA—muscle cancer	1.95e-05	0.000288	CbGpPWpGaD
Olanzapine—ADRA2B—Signaling Pathways—KIT—muscle cancer	1.93e-05	0.000285	CbGpPWpGaD
Olanzapine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—muscle cancer	1.93e-05	0.000285	CbGpPWpGaD
Olanzapine—HTR1B—Signaling Pathways—MDM2—muscle cancer	1.93e-05	0.000285	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling Pathways—FOXO1—muscle cancer	1.93e-05	0.000284	CbGpPWpGaD
Olanzapine—HRH4—Signaling Pathways—TP53—muscle cancer	1.92e-05	0.000283	CbGpPWpGaD
Olanzapine—DRD4—Signaling Pathways—MDM2—muscle cancer	1.9e-05	0.00028	CbGpPWpGaD
Olanzapine—CHRM4—Signaling Pathways—MDM2—muscle cancer	1.87e-05	0.000277	CbGpPWpGaD
Olanzapine—HTR1A—Signaling Pathways—KIT—muscle cancer	1.87e-05	0.000276	CbGpPWpGaD
Olanzapine—HTR2C—Signaling Pathways—KIT—muscle cancer	1.86e-05	0.000274	CbGpPWpGaD
Olanzapine—HTR2B—Signaling Pathways—MDM2—muscle cancer	1.81e-05	0.000268	CbGpPWpGaD
Olanzapine—ADRA2C—Signaling Pathways—KIT—muscle cancer	1.81e-05	0.000267	CbGpPWpGaD
Olanzapine—CHRM5—Signaling Pathways—MDM2—muscle cancer	1.79e-05	0.000265	CbGpPWpGaD
Olanzapine—CYP3A4—Metabolism—MED12—muscle cancer	1.79e-05	0.000264	CbGpPWpGaD
Olanzapine—ADRA1B—Signaling Pathways—KIT—muscle cancer	1.78e-05	0.000262	CbGpPWpGaD
Olanzapine—DRD1—Signaling Pathways—MDM2—muscle cancer	1.71e-05	0.000252	CbGpPWpGaD
Olanzapine—DRD3—Signaling Pathways—MDM2—muscle cancer	1.69e-05	0.000249	CbGpPWpGaD
Olanzapine—HTR1E—Signaling Pathways—TP53—muscle cancer	1.67e-05	0.000246	CbGpPWpGaD
Olanzapine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—muscle cancer	1.65e-05	0.000244	CbGpPWpGaD
Olanzapine—ADRA2C—Metabolism—PTGS2—muscle cancer	1.64e-05	0.000242	CbGpPWpGaD
Olanzapine—DRD2—Signaling Pathways—KIT—muscle cancer	1.64e-05	0.000242	CbGpPWpGaD
Olanzapine—CYP3A4—Metabolism—ENO2—muscle cancer	1.63e-05	0.000241	CbGpPWpGaD
Olanzapine—HTR2A—Signaling Pathways—KIT—muscle cancer	1.61e-05	0.000238	CbGpPWpGaD
Olanzapine—HRH1—Signaling Pathways—KIT—muscle cancer	1.61e-05	0.000238	CbGpPWpGaD
Olanzapine—CHRM1—Signaling Pathways—KIT—muscle cancer	1.6e-05	0.000237	CbGpPWpGaD
Olanzapine—CHRM3—Signaling Pathways—KIT—muscle cancer	1.6e-05	0.000236	CbGpPWpGaD
Olanzapine—CHRM2—Signaling Pathways—KIT—muscle cancer	1.58e-05	0.000234	CbGpPWpGaD
Olanzapine—ADRA1A—Signaling Pathways—KIT—muscle cancer	1.58e-05	0.000233	CbGpPWpGaD
Olanzapine—ALB—Hemostasis—TP53—muscle cancer	1.54e-05	0.000228	CbGpPWpGaD
Olanzapine—ADRA2B—Signaling Pathways—MDM2—muscle cancer	1.52e-05	0.000225	CbGpPWpGaD
Olanzapine—HTR6—Signaling Pathways—VEGFA—muscle cancer	1.51e-05	0.000223	CbGpPWpGaD
Olanzapine—HTR7—Signaling Pathways—VEGFA—muscle cancer	1.51e-05	0.000222	CbGpPWpGaD
Olanzapine—HTR1D—Signaling Pathways—VEGFA—muscle cancer	1.5e-05	0.000221	CbGpPWpGaD
Olanzapine—HRH2—Signaling Pathways—TP53—muscle cancer	1.49e-05	0.000219	CbGpPWpGaD
Olanzapine—DRD5—Signaling Pathways—TP53—muscle cancer	1.48e-05	0.000218	CbGpPWpGaD
Olanzapine—HTR1A—Signaling Pathways—MDM2—muscle cancer	1.47e-05	0.000217	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling Pathways—KIT—muscle cancer	1.47e-05	0.000217	CbGpPWpGaD
Olanzapine—HTR1B—Signaling Pathways—VEGFA—muscle cancer	1.47e-05	0.000216	CbGpPWpGaD
Olanzapine—HTR2C—Signaling Pathways—MDM2—muscle cancer	1.46e-05	0.000216	CbGpPWpGaD
Olanzapine—CHRM3—Metabolism—PTGS2—muscle cancer	1.45e-05	0.000214	CbGpPWpGaD
Olanzapine—DRD4—Signaling Pathways—VEGFA—muscle cancer	1.44e-05	0.000213	CbGpPWpGaD
Olanzapine—CHRM4—Signaling Pathways—VEGFA—muscle cancer	1.42e-05	0.00021	CbGpPWpGaD
Olanzapine—ADRA2C—Signaling Pathways—MDM2—muscle cancer	1.42e-05	0.00021	CbGpPWpGaD
Olanzapine—ADRA1B—Signaling Pathways—MDM2—muscle cancer	1.4e-05	0.000207	CbGpPWpGaD
Olanzapine—HTR2B—Signaling Pathways—VEGFA—muscle cancer	1.38e-05	0.000203	CbGpPWpGaD
Olanzapine—CHRM5—Signaling Pathways—VEGFA—muscle cancer	1.36e-05	0.000201	CbGpPWpGaD
Olanzapine—ADRA2A—Metabolism—PTGS2—muscle cancer	1.33e-05	0.000197	CbGpPWpGaD
Olanzapine—DRD1—Signaling Pathways—VEGFA—muscle cancer	1.3e-05	0.000192	CbGpPWpGaD
Olanzapine—DRD2—Signaling Pathways—MDM2—muscle cancer	1.29e-05	0.000191	CbGpPWpGaD
Olanzapine—DRD3—Signaling Pathways—VEGFA—muscle cancer	1.28e-05	0.000189	CbGpPWpGaD
Olanzapine—HTR2A—Signaling Pathways—MDM2—muscle cancer	1.27e-05	0.000188	CbGpPWpGaD
Olanzapine—HRH1—Signaling Pathways—MDM2—muscle cancer	1.27e-05	0.000187	CbGpPWpGaD
Olanzapine—CHRM1—Signaling Pathways—MDM2—muscle cancer	1.26e-05	0.000187	CbGpPWpGaD
Olanzapine—CHRM3—Signaling Pathways—MDM2—muscle cancer	1.26e-05	0.000186	CbGpPWpGaD
Olanzapine—CHRM2—Signaling Pathways—MDM2—muscle cancer	1.25e-05	0.000184	CbGpPWpGaD
Olanzapine—ADRA1A—Signaling Pathways—MDM2—muscle cancer	1.24e-05	0.000184	CbGpPWpGaD
Olanzapine—ADRA2B—Signaling Pathways—VEGFA—muscle cancer	1.16e-05	0.000171	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling Pathways—MDM2—muscle cancer	1.16e-05	0.000171	CbGpPWpGaD
Olanzapine—HTR6—Signaling Pathways—TP53—muscle cancer	1.14e-05	0.000168	CbGpPWpGaD
Olanzapine—HTR7—Signaling Pathways—TP53—muscle cancer	1.14e-05	0.000168	CbGpPWpGaD
Olanzapine—HTR1D—Signaling Pathways—TP53—muscle cancer	1.13e-05	0.000167	CbGpPWpGaD
Olanzapine—HTR1A—Signaling Pathways—VEGFA—muscle cancer	1.12e-05	0.000165	CbGpPWpGaD
Olanzapine—HTR2C—Signaling Pathways—VEGFA—muscle cancer	1.11e-05	0.000164	CbGpPWpGaD
Olanzapine—HTR1B—Signaling Pathways—TP53—muscle cancer	1.11e-05	0.000163	CbGpPWpGaD
Olanzapine—DRD4—Signaling Pathways—TP53—muscle cancer	1.09e-05	0.000161	CbGpPWpGaD
Olanzapine—ADRA2C—Signaling Pathways—VEGFA—muscle cancer	1.08e-05	0.000159	CbGpPWpGaD
Olanzapine—CHRM4—Signaling Pathways—TP53—muscle cancer	1.07e-05	0.000159	CbGpPWpGaD
Olanzapine—ADRA1B—Signaling Pathways—VEGFA—muscle cancer	1.06e-05	0.000157	CbGpPWpGaD
Olanzapine—ALB—Metabolism—PTGS2—muscle cancer	1.05e-05	0.000155	CbGpPWpGaD
Olanzapine—HTR2B—Signaling Pathways—TP53—muscle cancer	1.04e-05	0.000154	CbGpPWpGaD
Olanzapine—CHRM5—Signaling Pathways—TP53—muscle cancer	1.03e-05	0.000152	CbGpPWpGaD
Olanzapine—DRD1—Signaling Pathways—TP53—muscle cancer	9.81e-06	0.000145	CbGpPWpGaD
Olanzapine—DRD2—Signaling Pathways—VEGFA—muscle cancer	9.8e-06	0.000145	CbGpPWpGaD
Olanzapine—DRD3—Signaling Pathways—TP53—muscle cancer	9.68e-06	0.000143	CbGpPWpGaD
Olanzapine—HTR2A—Signaling Pathways—VEGFA—muscle cancer	9.64e-06	0.000142	CbGpPWpGaD
Olanzapine—HRH1—Signaling Pathways—VEGFA—muscle cancer	9.62e-06	0.000142	CbGpPWpGaD
Olanzapine—CHRM1—Signaling Pathways—VEGFA—muscle cancer	9.59e-06	0.000142	CbGpPWpGaD
Olanzapine—CHRM3—Signaling Pathways—VEGFA—muscle cancer	9.56e-06	0.000141	CbGpPWpGaD
Olanzapine—CHRM2—Signaling Pathways—VEGFA—muscle cancer	9.47e-06	0.00014	CbGpPWpGaD
Olanzapine—ADRA1A—Signaling Pathways—VEGFA—muscle cancer	9.44e-06	0.000139	CbGpPWpGaD
Olanzapine—CYP2C19—Metabolism—PTGS2—muscle cancer	9.44e-06	0.000139	CbGpPWpGaD
Olanzapine—ABCB1—Metabolism—PTGS2—muscle cancer	9.21e-06	0.000136	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling Pathways—VEGFA—muscle cancer	8.77e-06	0.00013	CbGpPWpGaD
Olanzapine—ADRA2B—Signaling Pathways—TP53—muscle cancer	8.74e-06	0.000129	CbGpPWpGaD
Olanzapine—CYP2D6—Metabolism—PTGS2—muscle cancer	8.68e-06	0.000128	CbGpPWpGaD
Olanzapine—CYP2C9—Metabolism—PTGS2—muscle cancer	8.6e-06	0.000127	CbGpPWpGaD
Olanzapine—HTR1A—Signaling Pathways—TP53—muscle cancer	8.43e-06	0.000125	CbGpPWpGaD
Olanzapine—HTR2C—Signaling Pathways—TP53—muscle cancer	8.39e-06	0.000124	CbGpPWpGaD
Olanzapine—ADRA2C—Signaling Pathways—TP53—muscle cancer	8.16e-06	0.000121	CbGpPWpGaD
Olanzapine—ADRA1B—Signaling Pathways—TP53—muscle cancer	8.03e-06	0.000119	CbGpPWpGaD
Olanzapine—DRD2—Signaling Pathways—TP53—muscle cancer	7.4e-06	0.000109	CbGpPWpGaD
Olanzapine—CYP1A2—Metabolism—PTGS2—muscle cancer	7.35e-06	0.000109	CbGpPWpGaD
Olanzapine—HTR2A—Signaling Pathways—TP53—muscle cancer	7.29e-06	0.000108	CbGpPWpGaD
Olanzapine—HRH1—Signaling Pathways—TP53—muscle cancer	7.27e-06	0.000107	CbGpPWpGaD
Olanzapine—CHRM1—Signaling Pathways—TP53—muscle cancer	7.25e-06	0.000107	CbGpPWpGaD
Olanzapine—CHRM3—Signaling Pathways—TP53—muscle cancer	7.22e-06	0.000107	CbGpPWpGaD
Olanzapine—CHRM2—Signaling Pathways—TP53—muscle cancer	7.15e-06	0.000106	CbGpPWpGaD
Olanzapine—ADRA1A—Signaling Pathways—TP53—muscle cancer	7.13e-06	0.000105	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling Pathways—TP53—muscle cancer	6.63e-06	9.79e-05	CbGpPWpGaD
Olanzapine—CYP3A4—Metabolism—PTGS2—muscle cancer	5.67e-06	8.38e-05	CbGpPWpGaD
